3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Hematologic Neoplasms
1
Graft vs Host Disease
1
Interventions
Radiotherapy
138
Cyclophosphamide
108
Cisplatin
103
Doxorubicin
99
Vincristine
76
Filgrastim
60
Etoposide
58
Paclitaxel
56
Carboplatin
53
Fluorouracil
51
Methotrexate
49
Dexamethasone
49
Cytarabine
43
Prednisone
42
Leucovorin
40
Granulocyte Colony-Stimulating Factor
34
Docetaxel
34
Radiation
31
Specimen Handling
30
Tamoxifen
27
Daunorubicin
27
Magnetic Resonance Spectroscopy
26
Calcium Dobesilate
26
Ifosfamide
25
Mercaptopurine
24
Gemcitabine
24
Platinum
22
Goserelin
22
1,2-diaminocyclohexaneplatinum II citrate
22
Chemotherapy, Adjuvant
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
NETWORK
×
trihexyltetradecylphosphonium chloride
×
Clear all
NCT05158608
2022-01-11
CY25
National Research Center for Hematology, Russia
Phase 3
Unknown
100 enrolled